3M/$MMM
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About 3M
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities and for pioneering new uses for its proprietary technologies. 3M has three business segments: safety and industrial (around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.
- Ticker
- $MMM
- Sector
- Industrials
- Primary listing
- NYSE
- Employees
- 60,500
- Headquarters
- Saint Paul, United States
- Website
- www.3m.com
3M Metrics
BasicAdvanced
$96B
27.71
$6.68
1.06
$3.07
1.69%
Price and volume
Market cap
$96B
Beta
1.06
52-week high
$196.90
52-week low
$139.34
Average daily volume
3.6M
Dividend rate
$3.07
Financial strength
Current ratio
1.408
Quick ratio
0.78
Long term debt to equity
2.531
Total debt to equity
3.035
Dividend payout ratio (TTM)
78.56%
Interest coverage (TTM)
5.93%
Profitability
EBITDA (TTM)
6,427
Gross margin (TTM)
39.53%
Net profit margin (TTM)
14.01%
Operating margin (TTM)
20.09%
Effective tax rate (TTM)
19.18%
Revenue per employee (TTM)
$420,000
Management effectiveness
Return on assets (TTM)
8.22%
Return on equity (TTM)
72.97%
Valuation
Price to earnings (TTM)
27.707
Price to revenue (TTM)
3.854
Price to book
22.95
Price to tangible book (TTM)
-18.3
Price to free cash flow (TTM)
36.344
Free cash flow yield (TTM)
2.75%
Free cash flow per share (TTM)
5.094
Dividend yield (TTM)
1.66%
Forward dividend yield
1.69%
Growth
Revenue change (TTM)
1.70%
Earnings per share change (TTM)
6.73%
3-year revenue growth (CAGR)
-1.83%
10-year revenue growth (CAGR)
-1.74%
3-year earnings per share growth (CAGR)
-20.66%
10-year earnings per share growth (CAGR)
-1.70%
3-year dividend per share growth (CAGR)
-19.97%
10-year dividend per share growth (CAGR)
-3.44%
What the Analysts think about 3M
Analyst ratings (Buy, Hold, Sell) for 3M stock.
Analyst projections of the future price of 3M stock.
Bulls say / Bears say
Q3 adjusted organic sales grew 3.3%, adjusted operating margin expanded 110 basis points to 26.2%, and adjusted EPS rose 12%. 3M raised its 2026 adjusted EPS forecast to $9.10–$9.15, showing that productivity gains are lifting earnings. (3M)
Safety and Industrial grew 7% organically in Q3, while electrical markets posted double-digit growth as data-centre demand strengthened. An expanded Amazon relationship could help 3M scale its optical-connectivity products into that market. (3M)
The new settlement is designed to resolve about 99% of current PFAS personal-injury claims, reducing a major source of litigation uncertainty. Payments are spread over nine years, with none due in 2027, easing the near-term cash timetable. (3M)
Growth remains uneven: Q3 organic sales rose only 0.5% in Transportation and Electronics, while Consumer sales fell 0.2%. Weakness in consumer electronics and automotive leaves the company needing a stronger finish to meet its full-year growth outlook. (3M)
Data summarised monthly by Lightyear AI. Last updated on 4 Nov 2026.
3M Financial Performance
Revenues and expenses
3M Earnings Performance
Company profitability
Upcoming events
3M News
AllArticlesVideos

A $7.4 Billion Legal Bill Sounds Bad. For 3M Stock, It's Pure Relief.
Barrons4 days ago

3M Reaches $7.35B PFAS Personal Injury Settlement, Maintains 2026 Outlook
MarketBeat4 days ago

Baron & Budd and Douglas & London Obtain $7.350 Billion Settlement With 3M Company to Resolve PFAS Personal Injury Lawsuits
Business Wire5 days ago
Funds containing 3M
AllUSDEURGBP
Fund name | Fund size | $MMM weighting |
|---|---|---|
Xtrackers Electrification Technologies & Smart Grid£WIRG | $144M | 5.87% |
iShares Dow Jones Industrial Average€EXI3 | €315M | 2.16% |
JPMorgan US Equity Premium Income£JEIP | $532M | 1.97% |
JPMorgan US Equity Premium Income$JEPI | $532M | 1.97% |
iShares S&P 500 Industrials Sector€2B7C | $787M | 1.87% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.